Abstract
Marked increases in the brain expression of interleukin (IL)-1 have been reported in rats after permanent occlusion of a large cerebral artery. Interactions between endothelial cells and leukocytes have been implicated in the pathogenesis of several types of ischemic injury to the myocardium and other organs. In this study we asked whether inhibiting the effects of IL-1 would affect the outcome of an experimental brain infarct. Adult male Wistar rats (n = 13) with permanent occlusion of the middle cerebral artery were given IL-1 receptor antagonist. A second group (n = 13) with the same type of brain injury was given a placebo. A third group, subjected to a sham operation, was given either IL-1 receptor antagonist (n = 2) or a placebo (n = 2). Experiments were terminated after either 24 hours or 7 days. Compared with the control group, animals treated with IL-1 receptor antagonist improved their neurological score (P < 0.05), experienced less pronounced changes in body weight (P < 0.05), and had fewer necrotic neurons (P < 0.001) and fewer leukocytes in the ischemic hemisphere (P < 0.001) as well as a smaller area of pallor (P < 0.05) in the ischemis hemisphere. The results suggest that inhibiting the proinflammatory effects of IL-1 with a receptor antagonist is an effective way of influencing the leukocyte responses elicited by an arterial occlusion. Such leukocyte inhibition seemingly attenuates the number of necrotic neurons resulting from the occlusion of a large brain artery.
Full text
PDF![1477](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/28fb71219420/amjpathol00047-0311.png)
![1478](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/c28ca0b4f772/amjpathol00047-0312.png)
![1479](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/32f4b87b817f/amjpathol00047-0313.png)
![1480](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/44a43883af83/amjpathol00047-0314.png)
![1481](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/d34c9153015c/amjpathol00047-0315.png)
![1482](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/685eccf24116/amjpathol00047-0316.png)
![1483](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/dae7b515ead7/amjpathol00047-0317.png)
![1484](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/58c1d057cb9d/amjpathol00047-0318.png)
![1485](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/2e5b4406958e/amjpathol00047-0319.png)
![1486](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/1869513/c073c0290c8c/amjpathol00047-0320.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alberts M. J. Genetic aspects of cerebrovascular disease. Stroke. 1991 Feb;22(2):276–280. doi: 10.1161/01.str.22.2.276. [DOI] [PubMed] [Google Scholar]
- Chen H., Chopp M., Zhang R. L., Bodzin G., Chen Q., Rusche J. R., Todd R. F., 3rd Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol. 1994 Apr;35(4):458–463. doi: 10.1002/ana.410350414. [DOI] [PubMed] [Google Scholar]
- Conti P. Interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra). Ann Med Interne (Paris) 1991;142(7):521–525. [PubMed] [Google Scholar]
- Dinarello C. A. Interleukin-1. Adv Pharmacol. 1994;25:21–51. doi: 10.1016/s1054-3589(08)60429-9. [DOI] [PubMed] [Google Scholar]
- Ember J. A., del Zoppo G. J., Mori E., Thomas W. S., Copeland B. R., Hugli T. E. Polymorphonuclear leukocyte behavior in a nonhuman primate focal ischemia model. J Cereb Blood Flow Metab. 1994 Nov;14(6):1046–1054. doi: 10.1038/jcbfm.1994.137. [DOI] [PubMed] [Google Scholar]
- Ernst E., Matrai A., Paulsen F. Leukocyte rheology in recent stroke. Stroke. 1987 Jan-Feb;18(1):59–62. doi: 10.1161/01.str.18.1.59. [DOI] [PubMed] [Google Scholar]
- Garcia J. H., Liu K. F., Ho K. L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke. 1995 Apr;26(4):636–643. doi: 10.1161/01.str.26.4.636. [DOI] [PubMed] [Google Scholar]
- Garcia J. H., Liu K. F., Yoshida Y., Chen S., Lian J. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol. 1994 Sep;145(3):728–740. [PMC free article] [PubMed] [Google Scholar]
- Garcia J. H., Liu K. F., Yoshida Y., Lian J., Chen S., del Zoppo G. J. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol. 1994 Jan;144(1):188–199. [PMC free article] [PubMed] [Google Scholar]
- Garcia J. H., Wagner S., Liu K. F., Hu X. J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995 Apr;26(4):627–635. doi: 10.1161/01.str.26.4.627. [DOI] [PubMed] [Google Scholar]
- Garcia J. H., Yoshida Y., Chen H., Li Y., Zhang Z. G., Lian J., Chen S., Chopp M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol. 1993 Feb;142(2):623–635. [PMC free article] [PubMed] [Google Scholar]
- Gerlach H., Gerlach M., Clauss M. Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure. Eur J Anaesthesiol. 1993 Jul;10(4):273–285. [PubMed] [Google Scholar]
- Ghezzi P., Dinarello C. A., Bianchi M., Rosandich M. E., Repine J. E., White C. W. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 1991 May;3(3):189–194. doi: 10.1016/1043-4666(91)90015-6. [DOI] [PubMed] [Google Scholar]
- Gordon C. R., Merchant R. S., Marmarou A., Rice C. D., Marsh J. T., Young H. F. Effect of murine recombinant interleukin-1 on brain oedema in the rat. Acta Neurochir Suppl (Wien) 1990;51:268–270. doi: 10.1007/978-3-7091-9115-6_91. [DOI] [PubMed] [Google Scholar]
- Gutierrez E. G., Banks W. A., Kastin A. J. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol. 1994 Dec;55(2):153–160. doi: 10.1016/0165-5728(94)90005-1. [DOI] [PubMed] [Google Scholar]
- Kaplanski G., Farnarier C., Kaplanski S., Porat R., Shapiro L., Bongrand P., Dinarello C. A. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood. 1994 Dec 15;84(12):4242–4248. [PubMed] [Google Scholar]
- Liu T., McDonnell P. C., Young P. R., White R. F., Siren A. L., Hallenbeck J. M., Barone F. C., Feurestein G. Z. Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke. 1993 Nov;24(11):1746–1751. doi: 10.1161/01.str.24.11.1746. [DOI] [PubMed] [Google Scholar]
- Longa E. Z., Weinstein P. R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989 Jan;20(1):84–91. doi: 10.1161/01.str.20.1.84. [DOI] [PubMed] [Google Scholar]
- Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 1994 Jul;25(7):1469–1475. doi: 10.1161/01.str.25.7.1469. [DOI] [PubMed] [Google Scholar]
- McIntyre K. W., Stepan G. J., Kolinsky K. D., Benjamin W. R., Plocinski J. M., Kaffka K. L., Campen C. A., Chizzonite R. A., Kilian P. L. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med. 1991 Apr 1;173(4):931–939. doi: 10.1084/jem.173.4.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J Neurochem. 1992 Jan;58(1):390–392. doi: 10.1111/j.1471-4159.1992.tb09324.x. [DOI] [PubMed] [Google Scholar]
- Mori E., del Zoppo G. J., Chambers J. D., Copeland B. R., Arfors K. E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke. 1992 May;23(5):712–718. doi: 10.1161/01.str.23.5.712. [DOI] [PubMed] [Google Scholar]
- Morimoto A., Watanabe T., Sakata Y., Murakami N. Leukocytosis induced by microinjection of endogenous pyrogen or interleukin-1 into the preoptic and anterior hypothalamus. Brain Res. 1988 Dec 20;475(2):345–348. doi: 10.1016/0006-8993(88)90623-3. [DOI] [PubMed] [Google Scholar]
- Okada Y., Copeland B. R., Mori E., Tung M. M., Thomas W. S., del Zoppo G. J. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 1994 Jan;25(1):202–211. doi: 10.1161/01.str.25.1.202. [DOI] [PubMed] [Google Scholar]
- Quagliarello V. J., Wispelwey B., Long W. J., Jr, Scheld W. M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest. 1991 Apr;87(4):1360–1366. doi: 10.1172/JCI115140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Relton J. K., Rothwell N. J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull. 1992 Aug;29(2):243–246. doi: 10.1016/0361-9230(92)90033-t. [DOI] [PubMed] [Google Scholar]
- Rothwell N. J., Relton J. K. Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc Brain Metab Rev. 1993 Fall;5(3):178–198. [PubMed] [Google Scholar]
- Schmid-Schönbein G. W., Engler R. L. Granulocytes as active participants in acute myocardial ischemia and infarction. Am J Cardiovasc Pathol. 1987 Jan;1(1):15–30. [PubMed] [Google Scholar]
- Tamura A., Graham D. I., McCulloch J., Teasdale G. M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1(1):53–60. doi: 10.1038/jcbfm.1981.6. [DOI] [PubMed] [Google Scholar]
- Vasthare U. S., Heinel L. A., Rosenwasser R. H., Tuma R. F. Leukocyte involvement in cerebral ischemia and reperfusion injury. Surg Neurol. 1990 Apr;33(4):261–265. doi: 10.1016/0090-3019(90)90046-r. [DOI] [PubMed] [Google Scholar]
- Vermes I., Strik F. Altered leukocyte rheology in patients with chronic cerebrovascular disease. Stroke. 1988 May;19(5):631–633. doi: 10.1161/01.str.19.5.631. [DOI] [PubMed] [Google Scholar]
- Yabuuchi K., Minami M., Katsumata S., Yamazaki A., Satoh M. An in situ hybridization study on interleukin-1 beta mRNA induced by transient forebrain ischemia in the rat brain. Brain Res Mol Brain Res. 1994 Oct;26(1-2):135–142. doi: 10.1016/0169-328x(94)90084-1. [DOI] [PubMed] [Google Scholar]
- Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke. 1995 Apr;26(4):676–681. doi: 10.1161/01.str.26.4.676. [DOI] [PubMed] [Google Scholar]
- Zhang R. L., Chopp M., Li Y., Zaloga C., Jiang N., Jones M. L., Miyasaka M., Ward P. A. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology. 1994 Sep;44(9):1747–1751. doi: 10.1212/wnl.44.9.1747. [DOI] [PubMed] [Google Scholar]